| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Elevance Health, Inc. | Director | Common Stock | 4.19K | $2.23M | $532.68 | May 15, 2024 | Direct |
| Guardant Health, Inc. | Director | COMMON STOCK | 7.41K | $65.2K | $8.80 | Jun 15, 2022 | Direct |
| Immunocore Holdings plc | CHIEF EXECUTIVE OFFICER, Director | Employee Share Option (Right to Buy) | 282K | Feb 16, 2024 | Direct | ||
| ArriVent Biopharma, Inc. | Director | Stock Option (right to buy) | 17.9K | Jan 25, 2024 | Direct | ||
| Guardant Health, Inc. | Director | RESTRICTED STOCK UNITS | 0 | $24.20 | Jun 15, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ELV | Elevance Health, Inc. | May 15, 2024 | 1 | $0 | 4 | May 17, 2024 | Director |
| IMCR | Immunocore Holdings plc | Feb 16, 2024 | 1 | $0 | 4 | Feb 21, 2024 | CHIEF EXECUTIVE OFFICER, Director |
| AVBP | ArriVent Biopharma, Inc. | Jan 25, 2024 | 1 | $0 | 4 | Jan 29, 2024 | Director |
| AVBP | ArriVent Biopharma, Inc. | Jan 25, 2024 | 0 | $0 | 3 | Jan 25, 2024 | Director |
| IMCR | Immunocore Holdings plc | Jan 2, 2024 | 0 | $0 | 3 | Jan 2, 2024 | Chief Executive Officer, Director |
| ELV | Elevance Health, Inc. | May 10, 2023 | 1 | $0 | 4 | May 12, 2023 | Director |
| GH | Guardant Health, Inc. | Jun 15, 2022 | 2 | $0 | 4 | Jun 17, 2022 | Director |
| ELV | Anthem, Inc. | May 18, 2022 | 1 | $0 | 4 | May 20, 2022 | Director |
| GH | Guardant Health, Inc. | Jun 16, 2021 | 2 | $0 | 4 | Jun 21, 2021 | Director |
| ELV | Anthem, Inc. | May 26, 2021 | 1 | $0 | 4 | May 28, 2021 | Director |